Literature DB >> 21847068

European respiratory society/american thoracic society/international association for the study of lung cancer international multidisciplinary classification of lung adenocarcinoma: state of the art.

Christian Witt.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21847068     DOI： 10.1097/JTO.0b013e318224643b

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN： 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  8 in total

1.  A systematic dissection of the epigenomic heterogeneity of lung adenocarcinoma reveals two different subclasses with distinct prognosis and core regulatory networks.

Authors:  Chongze Yuan; Haojie Chen; Shiqi Tu; Hsin-Yi Huang; Yunjian Pan; Xiuqi Gui; Muyu Kuang; Xuxia Shen; Qiang Zheng; Yang Zhang; Chao Cheng; Hui Hong; Xiaoting Tao; Yizhou Peng; Xingxin Yao; Feilong Meng; Hongbin Ji; Zhen Shao; Yihua Sun
Journal:  Genome Biol       Date:  2021-05-17       Impact factor: 13.583

2.  The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.

Authors:  Siyuan Dong; Xiaohan Qu; Wenya Li; Xinwen Zhong; Peiwen Li; Shize Yang; Xitao Chen; Mingrui Shao; Lin Zhang
Journal:  J Hematol Oncol       Date:  2015-04-29       Impact factor: 17.388

3.  Centromere protein U expression promotes non-small-cell lung cancer cell proliferation through FOXM1 and predicts poor survival.

Authors:  Xinxin Wang; Diangang Chen; Jianbao Gao; Haixia Long; Haoran Zha; Anmei Zhang; Chi Shu; Li Zhou; Fei Yang; Bo Zhu; Wei Wu
Journal:  Cancer Manag Res       Date:  2018-12-14       Impact factor: 3.989

4.  The diagnostic value of a seven-autoantibody panel and a nomogram with a scoring table for predicting the risk of non-small-cell lung cancer.

Authors:  Weidong Wang; Runzhou Zhuang; Honghai Ma; Likui Fang; Zhitian Wang; Wang Lv; Jian Hu
Journal:  Cancer Sci       Date:  2020-03-19       Impact factor: 6.716

5.  Adjuvant treatment can improve prognosis in patients with non-small cell lung cancer ≤3 cm after sublobectomy: a propensity score analysis.

Authors:  Haibo Ma; Jiwei Cheng; Yongkui Yu; Baoxing Liu; Jianjun Qin; Wenqun Xing; Suxia Luo
Journal:  J Thorac Dis       Date:  2021-01       Impact factor: 2.895

6.  Non-genetic stratification reveals epigenetic heterogeneity and identifies vulnerabilities of glycolysis addiction in lung adenocarcinoma subtype.

Authors:  Xuming Song; Te Zhang; Hanlin Ding; Yipeng Feng; Wenmin Yang; Xuewen Yin; Bing Chen; Yingkuan Liang; Qixing Mao; Wenjie Xia; Guiping Yu; Lin Xu; Gaochao Dong; Feng Jiang
Journal:  Oncogenesis       Date:  2022-10-10       Impact factor: 6.524

7.  Elucidating Genomic Characteristics of Lung Cancer Progression from In Situ to Invasive Adenocarcinoma.

Authors:  Chanida Vinayanuwattikun; Florence Le Calvez-Kelm; Behnoush Abedi-Ardekani; David Zaridze; Anush Mukeria; Catherine Voegele; Maxime Vallée; Dewajani Purnomosari; Nathalie Forey; Geoffroy Durand; Graham Byrnes; James Mckay; Paul Brennan; Ghislaine Scelo
Journal:  Sci Rep       Date:  2016-08-22       Impact factor: 4.379

8.  Increased levels of the long noncoding RNA, HOXA-AS3, promote proliferation of A549 cells.

Authors:  Hongyue Zhang; Ying Liu; Lixin Yan; Min Zhang; Xiufeng Yu; Wei Du; Siqi Wang; Qiaozhi Li; He Chen; Yafeng Zhang; Hanliang Sun; Zhidong Tang; Daling Zhu
Journal:  Cell Death Dis       Date:  2018-06-13       Impact factor: 8.469
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.